Search Results - "Bänsch, D."

Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial by Willems, Stephan, Tilz, Roland Richard, Steven, Daniel, Kääb, Stefan, Wegscheider, Karl, Gellér, László, Meyer, Christian, Heeger, Christian-Hendrik, Metzner, Andreas, Sinner, Moritz F., Schlüter, Michael, Nordbeck, Peter, Eckardt, Lars, Bogossian, Harilaos, Sultan, Arian, Wenzel, Beate, Kuck, Karl-Heinz, Piorkowski, C., Lebedev, D., Kautzner, J., Sticherling, C., Deneke, T., Rostock, T., Ukena, C., Kuniss, M., Makimoto, H., Hindricks, G., Bänsch, D., Schreieck, J., Kolb, C., Geller, J., Pokushalov, E., Gutleben, K., Sommer, P., Boldt, L.H., Parwani, A.

“…BACKGROUND:Catheter ablation for ventricular tachycardia (VT) reduces the recurrence of VT in patients with implantable cardioverter-defibrillators (ICDs). The…”
Get full text

New implantable cardiac monitor with three-lead ECG and active noise detection by Lauschke, J., Busch, M., Haverkamp, W., Bulava, A., Schneider, R., Andresen, D., Nägele, H., Israel, C., Hindricks, G., Bänsch, D.

“…Background A new implantable cardiac monitor (BioMonitor, Biotronik) with a continuous remote monitoring option was prospectively implanted in patients with…”
Get full text

Mapping and ablation of a left atrial macro reentrant tachycardia originating from the left superior pulmonary vein by Lauschke, J., Schneider, R., Bänsch, D.

Get full text

Single-catheter approach to pulmonary vein reisolation in selected patients: Data from a prospective registry by Lauschke, J., Schneider, R., Wissmann, J., Tischer, T., Bänsch, D.

“…Background In addition to different types of single-tip ablation catheters for pulmonary vein (PV) reisolation, a newly developed circular mapping and ablation…”
Get full text

Spontaneous left atrial reentry tachycardias: Radiofrequency ablation and outcome by Schneider, R., Schneider, C., Bänsch, D.

“…Aims Spontaneous left atrial reentry tachycardias (LART) in patients without previous cardiac surgical or catheter ablation are rare. Several therapeutic…”
Get full text

Surface and intracardiac ECG for discriminating conduction disorders after CoreValve implantation by Akin, I., Kische, S., Schneider, H., Liebold, A., Ortak, J., Bänsch, D., Rehders, T. C., Thiele, O., Schneider, R., Kundt, G., Krenz, H., Chatterjee, T., Nienaber, C. A., Ince, H.

“…Background Transcatheter aortic valve implantation (TAVI) has been developed to minimize operative morbidity and mortality in high-risk symptomatic patients…”
Get full text

Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators by Bänsch, Dietmar, Böcker, Dirk, Brunn, Jürgen, Weber, Max, Breithardt, Günter, Block, Michael

“…OBJECTIVES This retrospective study was undertaken to provide data on occurrence, significance and therapy of ventricular tachyarrhythmia (VT) clusters (VTCs)…”
Get full text

VT ablation in heart failure by Bänsch, D., Schneider, R., Akin, I., Nienaber, C.A.

“…Ventricular tachycardias (VT), shocks, and clusters of shock are ominous signs in patients with implantable cardioverter–defibrillators and herald an increased…”
Get full text

Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: Incidence, prediction and significance by BÄNSCH, D, CASTRUCCI, M, BÖCKER, D, BREITHARDT, G, BLOCK, M

“…This retrospective study was performed to provide data on ventricular tachycardias (VT) with a cycle length longer than the initially programmed tachycardia…”
Get full text

Ventricular tachycardia and sudden death after primary PCI-reperfusion therapy: Impact on primary prevention of sudden cardiac death by Paranskaya, L., Akin, I., Chatterjee, T., Ritz, A., Paranski, P., Rehders, T., Ince, H., Schneider, H., Nienaber, C.A., Bänsch, D.

“…Background Current approaches to coronary artery disease (CAD) and acute myocardial infarction (MI) may not be well represented in most primary prevention…”
Get full text

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS by Kirchhof, Paulus, Benussi, Stefano, Kotecha, Dipak, Ahlsson, Anders, Atar, Dan, Casadei, Barbara, Castella, Manuel, Diener, Hans-Christoph, Heidbuchel, Hein, Hendriks, Jeroen, Hindricks, Gerhard, Manolis, Antonis S, Oldgren, Jonas, Popescu, Bogdan Alexandru, Schotten, Ulrich, Van Putte, Bart, Vardas, Panagiotis

Get full text

Remote-controlled catheter ablation of accessory pathways: results from the magnetic laboratory by Chun, Julian Kyoung-Ryul, Ernst, Sabine, Matthews, Shibu, Schmidt, Boris, Bansch, Dietmar, Boczor, Sigrid, Ujeyl, Amaar, Antz, Matthias, Ouyang, Feifan, Kuck, Karl-Heinz

“…Aims This study evaluates feasibility, safety, and efficacy of magnetic remote-controlled accessory pathway (AP) ablation. Methods and results The novel…”
Get full text

Stellungnahme zum Einsatz des tragbaren Kardioverter/Defibrillators by Schwab, J.O., Bänsch, D., Israel, C., Nowak, B.

“…Zusammenfassung Der tragbare Kardioverter/Defibrillator (WCD) ist in der Lage, lebensbedrohliche ventrikuläre Tachyarrhythmien einschließlich Kammerflimmern zu…”
Get full text

Basal growth hormone levels are positively correlated with high-density lipoprotein cholesterol levels in women by Bänsch, Dietmar, Dirkes-Kersting, Astrid, Schulte, Helmut, Assmann, Gerd, von Eckardstein, Arnold

“…Previous studies in patients with either a deficiency or an excess of growth hormone (GH) yielded contradictory results on the regulation of lipoprotein…”
Get full text

The HATCH and CHA2DS2-VASc scores: Prognostic value in pulmonary vein isolation by Schmidt, E.U., Schneider, R., Lauschke, J., Wendig, I., Bänsch, D.

“…Aims The HATCH score describes the risk of paroxysmal atrial fibrillation (Afib) progression, while the CHA 2 DS 2 vasc score depicts the risk of…”
Get full text

The HATCH and CHA^sub 2^DS^sub 2^-VASc scores: Prognostic value in pulmonary vein isolation by Schmidt, Eu, Schneider, R, Lauschke, J, Wendig, I, Bänsch, D

“…The HATCH score describes the risk of paroxysmal atrial fibrillation (Afib) progression, while the CHA^sub 2^DS^sub 2^vasc score depicts the risk of…”
Get full text

Kommentar zu den neuen ESC-Leitlinien zur Schrittmacher- und kardialen Resynchronisationstherapie by Israel, C.W., Bänsch, D., Breithardt, O., Butter, C., Klingenheben, T., Kolb, C., Lemke, B., Wiegand, U., Nowak, B.

“…Zusammenfassung Die Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Schrittmacher- und kardialen Resynchronisationstherapie (CRT) von 2007…”
Get full text

Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure by BÖCKER, D, BÄNSCH, D, HEINECKE, A, WEBER, M, BRUNN, J, HAMMEL, D, BORGGREFE, M, BREITHARDT, G, BLOCK, M

“…Whether patients with heart failure derive a benefit from therapy with implantable cardioverter-defibrillators (ICDs) has been questioned. The purpose of this…”
Get full text

The patient with chronic heart failure by Bänsch, D, Grönefeld, G

“…An expansion of the indications for the implantation of defibrillators (ICD) has not occurred as such in recent years. Nevertheless, an increase in the number…”
Get full text

Efficacy and Safety of the Initial Use of Stability and Onset Criteria in Implantable Cardioverter Defibrillators by WEBER, MAX, BÖCKER, DIRK, BÁNSCH, DIETMAR, BRUNN, JÜRGEN, CASTRUCCI, MARCO, GRADAUS, RAINER, BREITHARDT, GÜNTER, BLOCK, MICHAEL

“…Primary Programming of Stability and Onset Criteria. Introduction: Inappropriate therapies are the most frequent adverse event in patients with implantable…”
Get full text